Chia‐Ying K. Lam

481 total citations
13 papers, 290 citations indexed

About

Chia‐Ying K. Lam is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chia‐Ying K. Lam has authored 13 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chia‐Ying K. Lam's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Chia‐Ying K. Lam is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Chia‐Ying K. Lam collaborates with scholars based in United States. Chia‐Ying K. Lam's co-authors include Syd Johnson, Jeffrey L. Nordstrom, Paul A. Moore, Liqin Liu, Scott Koenig, Menglei Zhu, Jeffrey Schlom, Carol Nieroda, K. Y. Tsang and David J. Cole and has published in prestigious journals such as Blood, Cancer Research and Journal of Virology.

In The Last Decade

Chia‐Ying K. Lam

13 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chia‐Ying K. Lam United States 8 170 113 106 96 61 13 290
Anastasia Lanzi France 6 111 0.7× 96 0.8× 76 0.7× 103 1.1× 57 0.9× 9 271
Ryan P. Staupe United States 5 321 1.9× 142 1.3× 20 0.2× 65 0.7× 79 1.3× 9 416
Esther D. Quakkelaar Netherlands 10 288 1.7× 82 0.7× 29 0.3× 137 1.4× 121 2.0× 13 434
Julia Makinde United Kingdom 9 376 2.2× 189 1.7× 69 0.7× 37 0.4× 152 2.5× 16 522
I. AXBERG Sweden 10 316 1.9× 52 0.5× 112 1.1× 101 1.1× 68 1.1× 16 442
LaTonya D. Williams United States 6 151 0.9× 39 0.3× 66 0.6× 119 1.2× 54 0.9× 9 272
H Spits Netherlands 12 429 2.5× 83 0.7× 164 1.5× 29 0.3× 58 1.0× 17 526
Hongjin Bian United States 6 225 1.3× 56 0.5× 71 0.7× 16 0.2× 142 2.3× 9 347
Andreas Beck Germany 7 131 0.8× 103 0.9× 19 0.2× 110 1.1× 55 0.9× 9 293
Sujatha Iyengar United States 8 156 0.9× 75 0.7× 21 0.2× 203 2.1× 69 1.1× 12 359

Countries citing papers authored by Chia‐Ying K. Lam

Since Specialization
Citations

This map shows the geographic impact of Chia‐Ying K. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Ying K. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Ying K. Lam more than expected).

Fields of papers citing papers by Chia‐Ying K. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Ying K. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Ying K. Lam. The network helps show where Chia‐Ying K. Lam may publish in the future.

Co-authorship network of co-authors of Chia‐Ying K. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Ying K. Lam. A scholar is included among the top collaborators of Chia‐Ying K. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Ying K. Lam. Chia‐Ying K. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Dashti, Amir, Maud Mavigner, Nils Schoof, et al.. (2020). SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques. Journal of Virology. 94(21). 26 indexed citations
2.
Pollara, Justin, R. Whitney Edwards, Chia‐Ying K. Lam, et al.. (2020). Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules. Frontiers in Immunology. 11. 713–713. 9 indexed citations
3.
Huang, Ling, Kalpana Shah, Bhaswati Barat, et al.. (2020). Multispecific, Multivalent Antibody‐Based Molecules Engineered on the DART® and TRIDENTTM Platforms. Current Protocols in Immunology. 129(1). e95–e95. 12 indexed citations
4.
Liu, Liqin, Chia‐Ying K. Lam, Ralph Alderson, et al.. (2019). Abstract 1560: Selection of a bispecific trivalent HER2 x CD137 TRIDENT format providing optimal tumor-anchored immune co-stimulation. Immunology. 1560–1560. 1 indexed citations
5.
Liu, Liqin, Chia‐Ying K. Lam, Ralph Alderson, et al.. (2019). Abstract 1560: Selection of a bispecific trivalent HER2 x CD137 TRIDENT format providing optimal tumor-anchored immune co-stimulation. Cancer Research. 79(13_Supplement). 1560–1560. 2 indexed citations
6.
Liu, Liqin, Ling Huang, Yinhua Yang, et al.. (2019). Abstract 554: Tumor-antigen 5T4-dependent activation of the CD137 costimulatory pathway by bispecific 5T4 x CD137 x CD137 TRIDENT™ molecules. Cancer Research. 79(13_Supplement). 554–554. 1 indexed citations
7.
8.
Liu, Liqin, Chia‐Ying K. Lam, Yinhua Yang, et al.. (2017). Abstract 3642: Tumor-antigen expression-dependent activation of the CD137 costimulatory pathway by bispecific DART® proteins. Cancer Research. 77(13_Supplement). 3642–3642. 3 indexed citations
9.
Liu, Liqin, Chia‐Ying K. Lam, Yinhua Yang, et al.. (2016). MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies. Clinical Cancer Research. 23(6). 1506–1518. 59 indexed citations
10.
Sloan, Derek D., Chia‐Ying K. Lam, Alivelu Irrinki, et al.. (2015). Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells. PLoS Pathogens. 11(11). e1005233–e1005233. 81 indexed citations
11.
Zanin, Mark, Zhen–Yong Keck, G. Jonah Rainey, et al.. (2015). An Anti-H5N1 Influenza Virus FcDART Antibody Is a Highly Efficacious Therapeutic Agent and Prophylactic against H5N1 Influenza Virus Infection. Journal of Virology. 89(8). 4549–4561. 12 indexed citations
12.
Brien, James D., Soila Sukupolvi-Petty, Katherine L. Williams, et al.. (2013). Protection by Immunoglobulin Dual-Affinity Retargeting Antibodies against Dengue Virus. Journal of Virology. 87(13). 7747–7753. 15 indexed citations
13.
Tsang, K. Y., Menglei Zhu, Carol Nieroda, et al.. (1997). Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.. PubMed. 3(12 Pt 1). 2439–49. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastasia Lanzi Breakdown of academic impact, for papers by Ryan P. Staupe Breakdown of academic impact, for papers by Esther D. Quakkelaar Breakdown of academic impact, for papers by Julia Makinde Breakdown of academic impact, for papers by I. AXBERG Breakdown of academic impact, for papers by LaTonya D. Williams Breakdown of academic impact, for papers by H Spits Breakdown of academic impact, for papers by Hongjin Bian Breakdown of academic impact, for papers by Andreas Beck Breakdown of academic impact, for papers by Sujatha Iyengar
Rankless by CCL
2026